Correlation of thallium-201 uptake with proliferating cell nuclear antigen in brain tumours

Nuclear Medicine Communications

Volumn 21, Issue 9, 2000, Pages 803-810

  GUNGOR, F ^a   BEZIRCIOGLU, H ^b   GUVENÇ, G ^b   TEZCAN, M ^b   YILDIZ, A ^b   ULUC, E ^b   ISISAG, A ^b  

^a AKDENIZ UNIVERSITY   (Turkey)

^b Izmir Atatürk State Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; DIAGNOSTIC AGENT; THALLIUM;

ADULT; ARTICLE; BRAIN TUMOR; CELL DIVISION; FEMALE; GLIOMA; HUMAN; MALE; MENINGIOMA; MIDDLE AGED; PATHOLOGY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; BRAIN NEOPLASMS; CELL DIVISION; FEMALE; GLIOMA; HUMANS; MALE; MENINGIOMA; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034277967     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200009000-00004     Document Type: Article

References (24)

1. Gado MH, Phelps ME, Coleman RE. An extravascular component of contrast enhancement in cranial computed tomography. II. Contrast enhancement and the blood-tissue barrier. Radiology 1975; 117: 589-597.
2. Sage MR. Blood-brain barrier: phenomenon of increasing importance to the imaging clinician. Am J Roentgenol 1982; 138: 887-898.
3. Di Chiro G, DeLaPaz RL, Brooks RA et al. Glucose utilization of cerebral gliomas measured by F-18 fluorodeoxyglucose and positron emission tomography. Neurology 1982; 32: 1323-1329.
4. Patronas NJ, Di Chiro G, Kufta C et al. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 1985; 62: 816-822.
5. Ericson K, Liljia A, Bergstrom M et al. Positron emission tomography with C-11 methyl-L methionine, C-11 D-glucose, an Ga-68 EDTA in supratentorial tumors. J Comput Assist Tomogr 1985; 9: 683-689.
6. Slizofski WJ, Krishna L, Katsetos CD et al. Thallium imaging for brain tumors with results measured by a semiquantitative index and correlated with histopathology. Cancer 1994; 74(12): 3190-3197.
7. Black KL, Hawkins RA, Kim KT et al. Use of thallium-201 SPECT to quantitative malignancy grade of gliomas. J Neurosurg 1989; 71: 342-346.
8. Waxman AD. Thallium-201 in nuclear oncology. Nucl Med Ann 1991; 193-209.
9. Gungor F, Bezircioglu H, Guvenc G et al. Clinical evaluation of early and delayed thallium-201 SPECT imaging in supratentorial brain gliomas. Eur J Nucl Med 1995; 22: 866.
10. Ueda T, Kaji Y, Wakisaka S et al. Time sequential single photon emission computed tomography studies in brain tumor using thallium-201. Eur J Nucl Med 1993; 20: 138-145.
11. Taki S, Kakuda K, Kakuma K et al. Tl-201 SPET in the differential diagnosis of brain tumors. Nucl Med Commun 1999; 20: 637-645.
12. Tonami N, Hisada K. Thallium-201 SPECT in the evaluation of gliomas. J Nucl Med 1993; 34: 2089-2090.
13. Oriuchi N, Tamura M, Shibazaki T et al. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities. J Nucl Med 1993; 34: 2085-2089.
14. Ishibashi M, Taguchi A, Sugita Y et al. Thallium-201 in brain tumors: relationship between tumor cell activity in astrocytic tumor and proliferating cell nuclear antigen. J Nucl Med 1995; 36: 2201-2206.
15. Centeno BA, Louis DN, Kupsky WJ et al. The AgNOR technique, PCNA immunohistochemistry, and DNA ploidy in the evaluation of choroid plexus biopsy specimens. Am J Clin Pathol 1993; 100: 690-696.
16. Haapasalo HK, Sallinen PK, Helen PT et al. Comparison of three quantitation methods for PCNA immunostaining: applicability and relation to survival in 83 astrocytic neoplasms. J Pathol 1993; 171: 207-214.
17. Kernohan JW, Sayre GP. Tumors of the central nervous system. In: Atlas of Tumor Pathology, Section X, Fascicle 35. Washington, DC: Armed Forces Institute of Pathology, 1952: 129.
18. Jinnouchi S, Hoshi H, Ohnishi T et al. Thallium-201 SPECT for predicting histological types of meningiomas. J Nucl Med 1993; 34: 2091-2094.
19. Kowalczuk A, Macdonald RL, Amidei C et al. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery 1997; 41: 1028-1036.
20. Van Veelen ML, Avezat CJ, Kros JM, van Putten W, Vecht C. Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry 1998; 64: 581-587.
21. Oriuchi N, Tomiyoshi K, Inoue T et al. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma. J Nucl Med 1996; 37: 457-462.
22. Kaplan WD, Takvorian T, Morris JH, Rumbaugh CL, Connolly BT, Atkins HL. Thallium-201 brain imaging: a comparative study with pathological correlation. J Nucl Med 1987; 28: 47-52.
23. Kim KT, Black KL, Marciano D et al. Thallium-201 SPECT imaging of brain tumors: method and results. J Nucl Med 1990; 31: 965-969.
24. Mountz JM, Raymond PA, McKeever PE et al. Specific local-ization of thallium-201 in human high-grade astrocytoma by microautoradiography. Cancer Res 1989; 49: 4053-4056.